Home > Financial Ratios > LASA SUPERGENERICS

LASA SUPERGENERICS
Core EBITDA Margin

    Back to All Ratios
LASA SUPERGENERICS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

LASA SUPERGENERICS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 2.13-5.0911.6823.3317.91

What is the latest Core EBITDA Margin ratio of LASA SUPERGENERICS ?

The latest Core EBITDA Margin ratio of LASA SUPERGENERICS is 2.13 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20242.13
Mar2023-5.09
Mar202211.68
Mar202123.33
Mar202017.91

How is Core EBITDA Margin of LASA SUPERGENERICS Trending?

Years Core EBITDA Margin % Change
Mar2024 2.13
Positive
Mar2023 -5.09
Negative
Mar2022 11.68
-49.94
Mar2021 23.33
30.26
Mar2020 17.91 -

Other Financial Ratios of LASA SUPERGENERICS


Compare Core EBITDA Margin ratio of peers of LASA SUPERGENERICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LASA SUPERGENERICS ₹48.5 Cr -5.5% -12.1% -59.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,370.0 Cr 1.2% 5.5% 0.3% Stock Analytics
DIVIS LABORATORIES ₹168,802.0 Cr -1.8% -3.1% 8.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,841.0 Cr -2% 2.8% 19.2% Stock Analytics
CIPLA ₹121,481.0 Cr -0.7% -8.6% 2.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,220.0 Cr -1.5% -4.3% 2.5% Stock Analytics


LASA SUPERGENERICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LASA SUPERGENERICS

-5.5%

-12.1%

-59.9%

SENSEX

-0.1%

0.6%

9.8%


You may also like the below Video Courses